The response to lenalidomide of myelodysplastic syndrome patients with deletion del(5q) can be sequentially monitored in CD34+ progenitor cells

被引:3
作者
Mohr, Brigitte [1 ]
Oelschlaegel, Uta [1 ]
Thiede, Christian [1 ]
Stewart, Michelle Meredyth [1 ]
Ehninger, Gerhard [1 ]
Platzbecker, Uwe [1 ]
机构
[1] Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, D-04307 Dresden, Germany
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 03期
关键词
5Q DELETION; CHIMERISM; RELAPSE;
D O I
10.3324/haematol.13865
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:430 / 431
页数:2
相关论文
共 5 条
[1]   Myelodyslastic syndrome with isolated 5q deletion (5q-syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis [J].
Cazzola, Mario .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (07) :967-972
[2]   Efficacy of lenalidomide in myelodysplastic syndromes [J].
List, A ;
Kurtin, S ;
Roe, DJ ;
Buresh, A ;
Mahadevan, D ;
Fuchs, D ;
Rimsza, L ;
Heaton, R ;
Knight, R ;
Zeldis, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (06) :549-557
[3]   Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion [J].
List, Alan ;
Dewald, Gordon ;
Bennett, John ;
Giagounidis, Aristotle ;
Raza, Azra ;
Feldman, Eric ;
Powell, Bayard ;
Greenberg, Peter ;
Thomas, Deborah ;
Stone, Richard ;
Reeder, Craig ;
Wride, Kenton ;
Patin, John ;
Schmidt, Michele ;
Zeldis, Jerome ;
Knight, Robert .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1456-1465
[4]   Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation [J].
Mattsson, J ;
Uzunel, M ;
Tammik, L ;
Aschan, J ;
Ringdén, O .
LEUKEMIA, 2001, 15 (12) :1976-1985
[5]  
Thiede C, 2002, ANN HEMATOL, V81, pS27